3,7-Dimethyloct-6-en-1-yl (2R)-2-hydroxypropanoate
Common Name: |
3,7-Dimethyloct-6-en-1-yl (2R)-2-hydroxypropanoate |
IUPAC Name: |
3,7-dimethyloct-6-enyl (2R)-2-hydroxypropanoate |
Molecular Formula: |
C13H24O3 |
SMILES: |
CC(CCC=C(C)C)CCOC(=O)C(C)O |
Inchi: |
1S/C13H24O3/c1-10(2)6-5-7-11(3)8-9-16-13(15)12(4)14/h6,11-12,14H,5,7-9H2,1-4H3/t11?,12-/m1/s1 |
Inchi Key: |
YTDFICAIKNPZRO-PIJUOVFKSA-N |
Cas No: |
211238-85-6 |
Name |
Value |
Lipinski Violations |
0 |
Ghose Violations |
0 |
Veber Violations |
0 |
Egan Violations |
0 |
Muegge Violations |
0 |
Name |
Value |
Molecular Weight (g/mol) |
228.33 |
Mass (g/mol) |
228.173 |
Molar Refractivity |
66.58 |
Net Charge |
|
HBD |
1 |
HBA |
3 |
Rt Bonds |
8 |
Rings |
|
TPSA |
46.53 |
Hetero Atoms |
3 |
Heavy Atoms |
16 |
Aromatic Heavy Atoms |
0 |
Melting Point (°C) |
|
Boiling Point (°C@760.00mm Hg) |
321.88 |
Vapor Pressure (mmHg@25.00 °C) |
|
Vapor Density (Air =1) |
|
Fraction Csp3 |
0.77 |
LogP |
2.683 |
iLOGP |
3.28 |
XLOGP3 |
3.52 |
WLOGP |
2.68 |
MLOGP |
2.44 |
ESOL Log S |
-2.95 |
ESOL Solubility (mg/ml) |
0.259 |
ESOL Solubility (mol/l) |
0.001 |
ESOL Class: esol_class |
Soluble |
Ali Log S |
-4.18 |
Ali Solubility (mg/ml) |
0.02 |
Ali Solubility (mol/l) |
0 |
Ali Class |
Moderately soluble |
Silicos-IT LogSw |
-2.36 |
Silicos-IT Solubility (mg/ml) |
1 |
Silicos-IT Solubility (mol/l) |
0 |
Silicos-IT Class |
Soluble |
Name |
Value |
GI Absorption |
High |
BBB Permeable |
1 |
PgP Substrate |
0 |
Log Kp (cm/s) |
-5.19 |
Bioavailability Score |
0.55 |
Caco2 |
1 |
Human Intestinal Absorption |
1 |
Plasm Protein Binding |
0.826 |
CYP1A2 Inhibitor |
0 |
CYP2C19 Inhibitor |
0 |
CYP2C9 Inhibitor |
0 |
CYP2D6 inhibitor |
0 |
CYP3A4 inhibitor |
0 |
Ames mutagenesis |
0 |
Acute Oral Toxicity |
2.295 |
Carcinogenicity (Binary) |
0 |
Carcinogenicity (Trinary) |
Non-required |
Eye Irritation |
1 |
Hepatotoxicity |
0 |
Androgen Receptor Binding |
0 |
Aromatase Binding |
0 |
Estrogen Receptor Binding |
0 |
Glucocorticoid Receptor Binding |
0 |
Thyroid Receptor Binding |
0 |
BRCP inhibitor |
0 |
BSEP inhibitor |
0 |
OATP1B1 inhibitor |
1 |
OATP1B3 inhibitor |
1 |
OATP2B1 inhibitor |
0 |
OCT1 inhibitor |
0 |
OCT2 inhibitor |
0 |